ArticleActa ophthalmologica2026
Risk of rhegmatogenous retinal detachment following pars plana vitrectomy for full-thickness macular hole and epiretinal membrane in pseudophakic eyes.
Article in Acta ophthalmologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Risk of rhegmatogenous retinal detachment following pars plana vitrectomy for full-thickness macular hole and epiretinal membrane in pseudophakic eyes.Acta ophthalmologica · 2026Article
- Tele-Ophthalmology for Retinal Health Surveillance in Denmark.Ophthalmology and therapy · 2026Review
- The Visual Effectiveness and Cost-Effectiveness of Vitrectomy and Membrane Peeling for Primary Idiopathic Epiretinal Membranes (iERMs): A Systematic Review.Journal of ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo estimate the risk of rhegmatogenous retinal detachment (RRD) following pars plana vitrectomy (PPV) for full-thickness macular hole (FTMH) or epiretinal membrane (ERM) in pseudophakic eyes.
methodsWe conducted a nationwide Danish registry-based cohort study from 2010 to 2023. Eyes entered the study at phacoemulsification surgery (age ≥ 50) and were followed until outcome (RRD), exposure (PPV), or censoring (death, end of study, or competing events). PPV was analysed as a time-dependent exposure occurring after phacoemulsification surgery, with eyes considered exposed from the time of PPV onwards.
resultsA total of 680 858 eyes were included. Median follow-up was 4.8 years (IQR, 2.5-7.9) after phacoemulsification and 5.0 years (2.5-7.9) after PPV, with a median interval of 76 days (39-328) between procedures. The 1-year cumulative incidence of RRD after PPV for FTMH was 0.62% (95% CI, 0.40-0.93), significantly higher in males. For ERM, it was 0.43% (0.27-0.66), with no sex difference. Compared to phacoemulsification alone, the hazard ratio (HR) for RRD was increased in males operated on for FTMH (HR 2.60; 1.62-4.17) and in females operated on for ERM (HR 1.93; 1.07-3.49). Among those who remained event-free 1 year postoperatively, no significant difference in RRD risk was observed between groups.
conclusionsPPV in pseudophakic eyes has a low risk of RRD but higher than that of phacoemulsification surgery after the first year, with notable sex variations for FTMH. Among those who remained event-free 1 year postoperative, no difference in RRD risk was observed between PPV and phacoemulsification surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.